Abstract
Drug associated thrombotic microangiopathy (TMA) is a rare event causing thrombocytopenia, microangiopathic anemia, renal failure, and neurologic abnormalities. Here, we present a case of TMA that occurred during the first cycle of treatment with carfilzomib for relapsed multiple myeloma.
Original language | English (US) |
---|---|
Pages (from-to) | 308-310 |
Number of pages | 3 |
Journal | Journal of Clinical Apheresis |
Volume | 30 |
Issue number | 5 |
DOIs | |
State | Published - Oct 2015 |
Externally published | Yes |
Keywords
- carfilzomib
- multiple myeloma
- plasma exchange
- thrombotic microangiopathy
ASJC Scopus subject areas
- Hematology